This project aims to use protein based therapeutics to induce acute inflammation in the tumor microenvironment as a potential cancer therapy. It is our hope that inducing a local, temporary inflammatory state will cause increased recruitment of immune cells to the tumor that can then contribute to effective immune control.
|K. Dane Wittrup, Ph.D.
C. P. Dubbs Professor of Chemical Engineering and Bioengineering
Associate Director, Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
500 Main Street,
Cambridge, MA 02139
Office Phone: 617-253-4578
Department of Chemical Engineering
Department of Biological Engineering
Koch Institute for Integrative Cancer Research